Followers | 20 |
Posts | 1722 |
Boards Moderated | 0 |
Alias Born | 11/17/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 14, 2017 11:09:04 AM
If the N-Assay initially captured only 15% of tests at $150/per test, that could be $90 million in revenue. Not too bad.
The company has used this strawman argument for 10 years now: "IF this happened, THAT could happen". Fact is, none of it has ever happened and they've had 10 years. Thousands of revenue is a long way off from $90 million. Nanologix will never come close to producing that kind of revenue. They won't even produce $1 million.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM